ATHA: קפיטליזציית שוק Athira Pharma Corp

Athira Pharma, Inc. (ATHA) is an innovative biopharmaceutical business developing small molecules for the regeneration of neural connections in Alzheimer's disease through translational medicine. The company's growth relies on the development of phosgonimetone, which targets hepatocyte growth factor to restore synapses. This daily price chart reflects the price action of an asset with a market capitalization of 0.03. However, the vulnerability of market positions following failed tests shifts commercial success to a long-term horizon.

For Athira Pharma, Inc. (ATHA), market capitalization reflects the speculative value of the business in the absence of revenue. This metric is calculated as the product of the share price and the number of outstanding shares, measuring aggregate market demand. Analyzing the issuer's valuation on the exchange allows for the identification of critical capital support levels. In the current situation, this metric is based exclusively on remaining liquidity. Investors should consider the risk of a total loss of value in the event of failed clinical trials.